We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIL icon
3751
Instil Bio
TIL
$50.1M
$12K ﹤0.01%
945
+702
+289% +$34.7K
TNYA icon
3752
Tenaya Therapeutics
TNYA
$163M
$12K ﹤0.01%
6,220
-1,722
-22% -$4.2K
STLN
3753
Starling Oncology, Inc. Common Stock
STLN
$657M
$12K ﹤0.01%
7,021
+5,345
+319% +$15K
TRTX
3754
TPG RE Finance Trust
TRTX
$609M
$12K ﹤0.01%
1,704
-3,104
-65% -$22.9K
TTEC icon
3755
TTEC Holdings
TTEC
$77.9M
$12K ﹤0.01%
281
-5,615
-95% -$252K
UGP icon
3756
Ultrapar
UGP
$6.55B
$12K ﹤0.01%
4,941
-5,880
-54% -$14.7K
VERU icon
3757
Veru
VERU
$46.5M
$12K ﹤0.01%
219
+4
+2% +$329
VIAV icon
3758
Viavi Solutions
VIAV
$10.7B
$12K ﹤0.01%
1,113
-22,307
-95% -$269K
VNQ icon
3759
Vanguard Real Estate ETF
VNQ
$39.2B
$12K ﹤0.01%
148
-21,151
-99% -$1.75M
VNRX icon
3760
VolitionRx Ltd
VNRX
$6.47M
$12K ﹤0.01%
249
-534
-68% -$20.7K
VRM icon
3761
Vroom Inc
VRM
$56.8M
$12K ﹤0.01%
143
-58
-29% -$4.98K
VRME icon
3762
VerifyMe
VRME
$8.66M
$12K ﹤0.01%
10,729
+1,897
+21% +$2.31K
VRTS icon
3763
Virtus Investment Partners
VRTS
$1.13B
$12K ﹤0.01%
65
-2,043
-97% -$365K
WINA icon
3764
Winmark
WINA
$1.26B
$12K ﹤0.01%
51
-81
-61% -$19.3K
CCEC
3765
Capital Clean Energy Carriers
CCEC
$1.36B
$12K ﹤0.01%
+861
New +$12.4K
RIME
3766
Algorhythm Holdings
RIME
$5.79M
$12K ﹤0.01%
14
+6
+75% +$6.36K
PVLA
3767
Palvella Therapeutics
PVLA
$2.25B
$12K ﹤0.01%
146
-124
-46% -$9.96K
QVCGB
3768
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$12K ﹤0.01%
49
-67
-58% -$22.2K
SPRB
3769
Spruce Biosciences
SPRB
$151M
$12K ﹤0.01%
146
+48
+49% +$4.02K
PFIE
3770
DELISTED
Profire Energy, Inc
PFIE
$12K ﹤0.01%
11,156
+3,646
+49% +$3.71K
STER
3771
DELISTED
Sterling Check Corp. Common Stock
STER
$12K ﹤0.01%
749
-2,484
-77% -$40.1K
LLAP
3772
DELISTED
Terran Orbital Corporation
LLAP
$12K ﹤0.01%
7,384
-3,318
-31% -$7.21K
AMJ
3773
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$12K ﹤0.01%
535
+94
+21% +$2.06K
BPTH
3774
DELISTED
Bio-Path Holdings Inc
BPTH
$12K ﹤0.01%
381
+212
+125% +$9.29K
KVSA
3775
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$12K ﹤0.01%
1,184
-2,236
-65% -$22.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.